We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
-0.3%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$468B
AUM Growth
-$6.98B
Cap. Flow
+$2.33B
Cap. Flow %
0.5%
Top 10 Hldgs %
16.09%
Holding
2,594
New
78
Increased
1,210
Reduced
770
Closed
91

Top Buys

Rank Stock Value
1
NXPI icon
NXP Semiconductors
NXPI
+$1.36B
2
PM icon
Philip Morris
PM
+$1.3B
3
AMZN icon
Amazon
AMZN
+$1.21B
4
SYK icon
Stryker
SYK
+$1.12B
5
AET
Aetna Inc
AET
+$1.08B

Top Sells

Rank Stock Value
1
BHC icon
Bausch Health
BHC
+$1.46B
2
GILD icon
Gilead Sciences
GILD
+$1.1B
3
DIS icon
Walt Disney
DIS
+$866M
4
AKAM icon
Akamai
AKAM
+$703M
5
CMG icon
Chipotle Mexican Grill
CMG
+$647M

Sector Composition

Rank Sector Weight
1 Healthcare 20.69%
2 Consumer Discretionary 15.01%
3 Financials 13.64%
4 Technology 12.55%
5 Industrials 10.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UTEK
2176
DELISTED
Ultratech Inc.
UTEK
$280K ﹤0.01%
+12,800
New +$253K
VRN
2177
DELISTED
Veren
VRN
$278K ﹤0.01%
20,000
HCKT icon
2178
Hackett Group
HCKT
$276M
$277K ﹤0.01%
18,320
APOL
2179
DELISTED
Apollo Education Group Inc Class A
APOL
$276K ﹤0.01%
33,620
+100
+0.3% +$795
RKUS
2180
DELISTED
RUCKUS WIRELESS INC COM STK (DE)
RKUS
$274K ﹤0.01%
27,900
WWE
2181
DELISTED
World Wrestling Entertainment
WWE
$272K ﹤0.01%
15,400
FC icon
2182
Franklin Covey
FC
$233M
$271K ﹤0.01%
15,432
+32
+0.2% +$546
BKS
2183
DELISTED
Barnes & Noble
BKS
$270K ﹤0.01%
21,884
ESND
2184
DELISTED
Essendant Inc.
ESND
$270K ﹤0.01%
8,446
OSG
2185
Octave Specialty Group
OSG
$211M
$269K ﹤0.01%
17,000
-3,800
-18% -$55K
BAC.PRL icon
2186
Bank of America Series L
BAC.PRL
$4.02B
$268K ﹤0.01%
237
-17
-7% -$18.8K
EWL icon
2187
iShares MSCI Switzerland ETF
EWL
$2.23B
$268K ﹤0.01%
+9,000
New +$262K
UMH
2188
UMH Properties
UMH
$1.41B
$268K ﹤0.01%
27,000
-5,300
-16% -$51K
THFF icon
2189
First Financial Corp
THFF
$976M
$266K ﹤0.01%
7,780
ITCI
2190
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$266K ﹤0.01%
+9,570
New +$319K
BMTC
2191
DELISTED
Bryn Mawr Bank Corp
BMTC
$266K ﹤0.01%
10,350
MACK
2192
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$266K ﹤0.01%
4,042
OUTR
2193
DELISTED
OUTERWALL INC
OUTR
$266K ﹤0.01%
7,200
WNC icon
2194
Wabash National
WNC
$530M
$265K ﹤0.01%
20,100
EXCU
2195
DELISTED
Exelon Corporation
EXCU
$265K ﹤0.01%
5,483
-440
-7% -$19.6K
MXWL
2196
DELISTED
Maxwell Technologies Inc
MXWL
$264K ﹤0.01%
44,500
PACB icon
2197
Pacific Biosciences
PACB
$357M
$263K ﹤0.01%
30,900
TTMI icon
2198
TTM Technologies
TTMI
$14.9B
$262K ﹤0.01%
39,450
HOV icon
2199
Hovnanian Enterprises
HOV
$803M
$260K ﹤0.01%
6,668
PRSU
2200
Pursuit Attractions and Hospitality Inc
PRSU
$1.28B
$260K ﹤0.01%
8,927

Similar funds

T. Rowe Price Associates's Q1 2016 Portfolio in Review

As of Q1 2016, T. Rowe Price Associates held 2,594 positions worth $468B, down 1.5% from $475B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

T. Rowe Price Associates's Q1 2016 filing shows 78 new, 1,210 increased, 770 reduced and 91 closed positions. Its largest new stake was BRF SA: 5,750,603 shares worth $81.8M. The largest sale was Bausch Health, an estimated $1.46B.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, down from 22% a quarter earlier, followed by Consumer Discretionary and Financials.

  • T. Rowe Price Associates's largest Q1 2016 buy was BRF SA: 5,750,603 shares worth $81.8M.
  • T. Rowe Price Associates added most to NXP Semiconductors in Q1 2016, an estimated $1.36B increase.
  • T. Rowe Price Associates's biggest Q1 2016 reduction was Bausch Health, cutting an estimated $1.46B.
  • T. Rowe Price Associates fully exited CHUBB CORPORATION in Q1 2016, selling an estimated $496M.
  • T. Rowe Price Associates's ten largest holdings make up 16% of its $468B portfolio in Q1 2016.
  • T. Rowe Price Associates opened 78 new positions and closed 91 in Q1 2016.
  • T. Rowe Price Associates's portfolio value fell 1.5% quarter-over-quarter to $468B.

Based on T. Rowe Price Associates's 13F filing for Q1 2016, filed 16 May 2016.